Table 1.
Subject | Control Group | THR Group | |
---|---|---|---|
Sex M:F | 5:8 | 5:7 | |
Age (years) | 66 (52–85) | 73 (59–83) | |
BMI | 27 (21–35) | 26 (19–30) | |
Height (cm) | 167 (156–180) | 169 (158–184) | |
Top Speed (km/h) | 6.9 (6–7.5)† | 5.9 (4–7.5) | |
Oxford Hip Score | NA | 45 (39–48) | |
EQ-5D | NA | 0.922 (0.735–1.000) | |
EQ-VAS | NA | 86 (75–100) | |
Short | Long | ||
Pre-op OA Severity | NA | 3 (2–4) | 3 (2–4) |
Follow-up (months) | NA | 31 (10–60)‡ | 79 (45–116) |
Inserted Side (Right) | NA | 7 | 5 |
Head Size (mm) | NA | 36 (32–40) | 36 (32–40) |
Cup Inclination (Degrees) | NA | 39 (37–43) | 41(37–44) |
Hip Offset Difference (Short-Long) mm | NA | − 1 (− 5–4) | |
Hip Length Difference (Short-Long) mm | NA | 1 (-4—5) |
The values are indicated as means (range)
†Significant difference between patient groups versus control (p < 0.05)
‡Significant difference between patient groups (p < 0.05)